Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- 5 April 2013
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 381 (9881), 1905-1915
- https://doi.org/10.1016/s0140-6736(13)60023-9
Abstract
No abstract availableFunding Information
- Juvenile Diabetes Research Foundation United States of America
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HHSN267200800019C, U01 DK061010, U01 DK061016, U01 DK061034, U01 DK061036, U01 DK061040, U01 DK061041, U01 DK061042, U01 DK061055, U01 DK061058, U01 DK084565, U01 DK085453, U01 DK085461, U01 DK085463, U01 DK085466, U01 DK085499, U01 DK085505, U01 DK085509)
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Research Resources (M01 RR00400, UL1 RR024139, UL1 RR024153, UL1 RR024975, UL1 RR024982, UL1 RR025744, UL1 RR025761, UL1 RR025780, UL1 RR029890, UL1 RR031986)
- National Institutes of Health
- American Diabetes Association (17-2008-1804, 8-2008-175)
- National Institute of Allergy and Infectious Diseases
This publication has 25 references indexed in Scilit:
- Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trialThe Lancet, 2011
- Short-term IL-1β blockade reduces monocyte CD11b integrin expression in an IL-8 dependent fashion in patients with type 1 diabetesClinical Immunology, 2010
- Blockade of interleukin 1 in type 1 diabetes mellitusNature Reviews Endocrinology, 2010
- Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell massDiabetologia, 2010
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell FunctionNew England Journal of Medicine, 2009
- Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 yearsClinical Immunology, 2009
- Etanercept Treatment in Children With New-Onset Type 1 DiabetesDiabetes Care, 2009
- GAD Treatment and Insulin Secretion in Recent-Onset Type 1 DiabetesNew England Journal of Medicine, 2008
- Gene Expression in Peripheral Blood Mononuclear Cells from Children with DiabetesJournal of Clinical Endocrinology & Metabolism, 2007
- Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 DiabetesNew England Journal of Medicine, 2005